Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDSA update from the city of brotherly love.

The Hopkins HIV report : a bimonthly newsletter for healthcare providers - 1 Jan 2000

Ghandi R

Abstract excerpt

Data from a major new trial called START II (Selection of Thymidine Analog Therapy), was presented at this year's Infectious Diseases Society of America (IDSA) conference. One trial compared d4T/ddI/IDV combination therapy with AZT/3TC/IDV in treatment-naive individuals. A second trial, CNA 3003, compared triple NRTI therapy with AZT/3TC/abacavir to dual therapy with AZT/3TC; patients who added abacavir to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS-Related Opportunistic Infections
Share to Anti-HIV Agents
Share to Congresses as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Therapy, Combination

Share to Drugs, Investigational

Share to HIV Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 11366315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDSA update from the city of brotherly love.PMID 11366315Read ↗

FDA triple header. Food and Drug Administration.Semantic proximity Read ↗

New principles of HIV-related medical care.Semantic proximity Read ↗

Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.Semantic proximity Read ↗

[Companion Diagnostics for Selecting Antiretroviral Drugs against HIV-1].Semantic proximity Read ↗

No compelling reason to adopt new antivirals whenever it is reasonable to wait.Semantic proximity Read ↗

Resistance: Crizotinib makes a comeback.Semantic proximity Read ↗

New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.Semantic proximity Read ↗

Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.Semantic proximity Read ↗

New antiretroviral drugs part I: PIs.Semantic proximity Read ↗

More clinical data on protease inhibitors.Semantic proximity Read ↗

Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosidesSemantic proximity Read ↗

Why you should consider early HIV treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.